Mankind Pharma's Stock Price Sees Strong Growth, Outperforms Market Average
Mankind Pharma, a leading pharmaceutical company in India, experienced a 3.54% increase in its stock price on May 14th, 2024, closing at Rs 2264.35 per share. This growth was higher than the sector average by 3.69%, indicating a strong performance. The company's stock is currently rated as 'Hold' by MarketsMojo, based on its financial performance and industry outlook. Mankind Pharma has consistently outperformed the market and remains a key player in the Indian pharmaceutical market.
Mankind Pharma, a leading pharmaceutical company in India, saw a positive growth in its stock price on May 14th, 2024. The stock gained 3.54%, closing at Rs 2264.35 per share. This increase in stock price was higher than the sector average by 3.69%, indicating a strong performance by the company.
According to MarketsMOJO, a leading stock market analysis platform, the stock of Mankind Pharma is currently rated as 'Hold'. This rating is based on various factors such as financial performance, market trends, and industry outlook.
The stock of Mankind Pharma has been consistently performing well, with its current price being higher than the 5-day, 50-day, 100-day, and 200-day moving averages. However, it is lower than the 20-day moving average, indicating a slight dip in performance in the short term.
In comparison to the overall market performance, Mankind Pharma has outperformed the Sensex by 3.60% in the past 1 day and -2.62% in the past 1 month. This showcases the company's strong position in the pharmaceutical industry.
With a large market capitalization, Mankind Pharma continues to be a key player in the Indian pharmaceutical market. Its consistent performance and positive growth in stock price make it a promising investment option for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
